Cargando…
Patent ductus arteriosus and oxidative stress in preterm infants: a narrative review
The role of oxygen, reactive oxygen species (ROS), and isoprostanes (IsoPs) in regulating patency and closure of patent ductus arteriosus (PDA) have been studied in preterm infants. Also the possible correlation between a hemodynamically significant PDA and its pharmacological treatment with oxidati...
Autores principales: | Dani, Carlo, Pratesi, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804476/ https://www.ncbi.nlm.nih.gov/pubmed/33457306 http://dx.doi.org/10.21037/tp-20-121 |
Ejemplares similares
-
Isoprostanes as Biomarker for Patent Ductus Arteriosus in Preterm Infants
por: Coviello, Caterina, et al.
Publicado: (2020) -
Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants
por: Arlettaz, Romaine
Publicado: (2017) -
Editorial: Management of Patent Ductus Arteriosus in Preterm Infants
por: Atasay, Begüm, et al.
Publicado: (2021) -
Multiscale Modeling Is Required for the Patent Ductus Arteriosus in Preterm Infants
por: Ho, Harvey, et al.
Publicado: (2022) -
Patent Ductus Arteriosus in Preterm Infants: Do We Have the Right Answers?
por: Abdel-Hady, Hesham, et al.
Publicado: (2013)